Pfizer Ltd
- Awards
- 9
- Value outside frameworks
- Framework places and shared awards only
- Framework places
- 5
- Shared awards
- 4
Values exclude VAT where the notices give it, and only values in pounds are added up. A framework place carries the framework's whole ceiling, shared with the other suppliers on it, so framework places are counted rather than added up; so are awards made to several suppliers together. Every award here is a framework place or shared.
Awards
| Procurement | Buyer | Value | Date |
|---|---|---|---|
| NHS National Generic Pharmaceuticals Wave 14a shared | NHS England | £207,982,407 | 14 Dec 2022 |
| NHS Framework Agreement for Branded medicines - National framework | NHS England | £526,000,000 | 16 May 2022 |
| NHS Framework for the North of England, Branded Medicine framework | NHS England | £238,913,892 | 7 Feb 2022 |
| NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual framework | NHS England | £216,078,796 | 7 Feb 2022 |
| NHS National Generic Pharmaceuticals Wave 13 shared | Atamis Ltd | £469,741,518 | 30 Nov 2021 |
| NHS National Generic Pharmaceuticals Wave 13 shared | Atamis Ltd | £469,741,550 | 30 Nov 2021 |
| NHS National Generic Pharmaceuticals Wave 13 shared | Atamis Ltd | £469,741,550 | 30 Nov 2021 |
| NHS Framework Agreement for Branded Medicines - National framework | NHS England | £95,224,871 | 27 Sep 2021 |
| NHS Framework Agreement, Branded Medicines for London and South of England framework | NHS England | £558,521,926 | 19 Aug 2021 |
Top buyers
| Buyer | Awards | Value |
|---|---|---|
| NHS England | 6 | - |
| Atamis Ltd | 3 | - |
By number of awards. Value is the total of awards made to this supplier alone outside frameworks, excluding VAT where the notices give it.